Aventis and Altana in asthma deal

AVE and Byk Gulden, the pharmaceutical group of Altana (Bad Homburg, Germany), will develop and market in the U.S. Byk Gulden's ciclesonide inhaled corticosteroid, which is in Phase III testing to tre...